Sanofi sues Mylan over anticompetitive practices; Anthem to drop Express Scripts; GSK chief digital officer says advertisers should focus on fewer publishers
Five things for pharma marketers to know: Tuesday, April 4, 2017
Mylan allegedly increased EpiPen list price to appease PBMs; 20% of patients misdiagnosed by primary-care doctor: study; Mallinckrodt settles DEA probe
Five things for pharma marketers to know: Tuesday, March 21, 2017
FDA solicits public comment to study online character space limit; Biogen’s Spinraza shows positive results in SMA study; Valeant cuts earnings forecast
Five things for pharma marketers to know: Wednesday, August 31, 2016
It’s possible that payers won’t prove the wild card in the PCSK9 derby. Instead, physician preference may do more to shape the market and maybe even force payers’ hands.
Five things for pharma marketers to know: Friday, December 11, 2015